You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: November 24, 2024

CLINICAL TRIALS PROFILE FOR IBUPROFEN AND PHENYLEPHRINE HYDROCHLORIDE


✉ Email this page to a colleague

« Back to Dashboard


All Clinical Trials for IBUPROFEN AND PHENYLEPHRINE HYDROCHLORIDE

Trial ID Title Status Sponsor Phase Start Date Summary
NCT00978757 ↗ The Effect of Ketamine on Interleukin-6 Synthesis in Hepatic Resections Requiring Temporary Porto-arterial Occlusion Completed Hospital Italiano de Buenos Aires Phase 4 2001-06-01 The purpose of this study is to determine whether ketamine is effective to inhibit interleukin 6 synthesis in hepatic resections requiring temporary porto-arterial occlusion.
NCT01938144 ↗ Evaluation of the Efficacy and Safety of Two Ibuprofen Combination Products for the Treatment of the Common Cold and Flu in Latin America Withdrawn Pfizer Phase 3 2016-04-01 This is a multicenter, prospective, randomized, double-blind, triple-dummy, parallel group, comparative, study designed to evaluate the efficacy of Ibuprofen (IBU) 200 mg/ Phenylephrine (PE) 10 mg and IBU 200 mg/ PE 10 mg/ Chlorpheniramine (CHLOR) 4 mg on the relief of symptoms of the common cold and flu. The reference product that the active treatments will be compared to is paracetamol (PARA) 500 mg.
NCT02904304 ↗ Desloratadine,Phenylephrine Hcl,Ibuprofen Compared to Placebo in Treatment of Symptoms Associated With Common Cold/Flu Suspended Ache Laboratorios Farmaceuticos S.A. Phase 3 2020-12-01 National clinical trial, phase III, multicenter, randomized, prospective, double-blind, parallel, placebo-controlled, which one hundred and fifty (150) subjects of both sexes aged equal or more than 18 years will be randomly allocated to one the drug group or placebo group.
>Trial ID >Title >Status >Phase >Start Date >Summary

Clinical Trial Conditions for IBUPROFEN AND PHENYLEPHRINE HYDROCHLORIDE

Condition Name

Condition Name for IBUPROFEN AND PHENYLEPHRINE HYDROCHLORIDE
Intervention Trials
Cold 1
Common Cold 1
Hepatectomy 1
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Condition MeSH

Condition MeSH for IBUPROFEN AND PHENYLEPHRINE HYDROCHLORIDE
Intervention Trials
Common Cold 2
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Clinical Trial Locations for IBUPROFEN AND PHENYLEPHRINE HYDROCHLORIDE

Trials by Country

Trials by Country for IBUPROFEN AND PHENYLEPHRINE HYDROCHLORIDE
Location Trials
Brazil 1
Argentina 1
This preview shows a limited data set
Subscribe for full access, or try a Trial

Clinical Trial Progress for IBUPROFEN AND PHENYLEPHRINE HYDROCHLORIDE

Clinical Trial Phase

Clinical Trial Phase for IBUPROFEN AND PHENYLEPHRINE HYDROCHLORIDE
Clinical Trial Phase Trials
Phase 4 1
Phase 3 2
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Clinical Trial Status

Clinical Trial Status for IBUPROFEN AND PHENYLEPHRINE HYDROCHLORIDE
Clinical Trial Phase Trials
Suspended 1
Withdrawn 1
Completed 1
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Clinical Trial Sponsors for IBUPROFEN AND PHENYLEPHRINE HYDROCHLORIDE

Sponsor Name

Sponsor Name for IBUPROFEN AND PHENYLEPHRINE HYDROCHLORIDE
Sponsor Trials
Hospital Italiano de Buenos Aires 1
Pfizer 1
Ache Laboratorios Farmaceuticos S.A. 1
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Sponsor Type

Sponsor Type for IBUPROFEN AND PHENYLEPHRINE HYDROCHLORIDE
Sponsor Trials
Industry 2
Other 1
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.